Advice on recruiting for Rx groups Post-MBA

Fortunate to be matriculating to a T15 MBA program. Planning on recruiting for investment banking. I am really interested in restructuring but I know how challenging placement is. I have 3yrs of valuation and transaction advisory experience at a reputable boutique. My work is mainly fairness opinions and general corporate buy/sell planning enagements for large sponsor backed private companies.

Is trying to recruit for restructing groups even feasible coming from a T15 MBA program (think Tuck/Anderson/Cornell/NYU)? Should I try to be more realistic and target M&A groups instead?

I took a look at most of the summer associates in PJT RSSG and the majority are Wharton and Harvard kids.

Would appreciate any advice. Thanks!

 

You should have a few options that come to your campus...reach out to the ones that don't. EBs are generally pretty lean so can't have a physical presence everywhere. It doesn't mean they won't consider you

PJT [and Lazard?] might be a little more difficult but the rest are fine

 
Most Helpful

My memory's foggy on the details but I wasn't asked restructuring technicals at all from the Rx shops but more just really tricky share price calc questions from very limited variables/ratios and accretion/dilution logic questions.
Actually the restructuring questions I got weren't from the Rx shops but BB's; understanding the levers to pull in de-leveraging a company, levers to pull to increase EBITDA and lower the leverage multiple, improve interest coverage ratios.
Besides knowing 400 questions forwards and backwards (also the WSO guide is great too as a substitute if you don't have the 400 guide), I would play with some DCF or merger models and play with the inputs to understand changes can increase or decrease the valuation.
And don't underestimate behaviorals; I remember being asked, "what makes you think you'd work well with analysts?" "How would you handle a difficult analyst?"

 

Aren't there a bunch of Dartmouth dudes at PJT? They must have all done their undergrads there if what you said is true. I would be very surprised if that place didn't hire associates beyond Wharton / Harvard given that they like never promote A2A.

Regardless, I would think hard about whether or not there's a clear career track at the firm you are considering. For example, a certain EB that all the kids here like to jerk off to is actually well known for having a clog of VPs in rx that are struggling to take the next step. Meanwhile there are firms like TRS where if you join now, you would probably have a very clear career path to MD (with the trade-off being near-term mandate quality and maybe exits). A happy medium might be something like PWP. They're not going to beat PJT every time on a pitch, but it's still an elite brand with an easily identifiable source of mandate growth (TPH acquisition -> energy rx mandates).

 

Also, assuming you graduated at 22, you're going to be in your late 20s by the time you come out of business school. If lifestyle is going to start being a concern, young, lean firms like TRS are almost always sweatshops (though obviously don't take my word for this and actually call someone at the firm to find out).

 

As an alternative if you're really interested in RX and you don't place at an IB, I'd suggest consulting (AM,Alix,FTI) you'll get to know the in and out of RX, gain relationships n can move over to either banking or fund if you're good at connecting with that group on deals.

FreezyD
 

Veritatis hic corporis atque rerum. Dolorem similique nesciunt magnam ea qui sed quo. Asperiores voluptatum et illum commodi nisi. Sunt rem at earum doloribus. Quas exercitationem totam officia rem unde est tempore. Ratione accusamus voluptatem corrupti ullam ex aliquid quod.

Rerum et cupiditate libero cupiditate. Asperiores molestiae quo unde. Nulla nam hic earum quas ut iure ab. Tenetur nesciunt quas magni eius placeat maiores accusamus molestiae. Nobis minima quisquam unde eius inventore odio magni. Esse et quaerat non nihil. Sed magnam ratione similique vitae.

Alias repellendus autem ullam perferendis et temporibus omnis. Maxime eos quas in magnam aliquam minima. Exercitationem accusantium vel iure ratione distinctio omnis perferendis.

Et magnam ea veritatis dolore. Ipsum dicta et ut ea quis minus numquam. Et tenetur accusantium quo omnis distinctio ut quos. Et unde natus sunt et.

Career Advancement Opportunities

April 2024 Investment Banking

  • Jefferies & Company 02 99.4%
  • Goldman Sachs 19 98.8%
  • Harris Williams & Co. New 98.3%
  • Lazard Freres 02 97.7%
  • JPMorgan Chase 03 97.1%

Overall Employee Satisfaction

April 2024 Investment Banking

  • Harris Williams & Co. 18 99.4%
  • JPMorgan Chase 10 98.8%
  • Lazard Freres 05 98.3%
  • Morgan Stanley 07 97.7%
  • William Blair 03 97.1%

Professional Growth Opportunities

April 2024 Investment Banking

  • Lazard Freres 01 99.4%
  • Jefferies & Company 02 98.8%
  • Goldman Sachs 17 98.3%
  • Moelis & Company 07 97.7%
  • JPMorgan Chase 05 97.1%

Total Avg Compensation

April 2024 Investment Banking

  • Director/MD (5) $648
  • Vice President (19) $385
  • Associates (87) $260
  • 3rd+ Year Analyst (14) $181
  • Intern/Summer Associate (33) $170
  • 2nd Year Analyst (66) $168
  • 1st Year Analyst (205) $159
  • Intern/Summer Analyst (146) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”